The global VCF market was valued at over $1.1 billion in 2024.
It is projected to grow at a CAGR of 5.2%, reaching over $1.6 billion by 2031.
The report covers two primary segments:
- Percutaneous Vertebral Augmentation (PVA)
- Vertebroplasty
Market Data Included
- Unit Sales
- Average Selling Prices (ASPs)
- Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts to 2031
- Historical Data to 2024
- Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitor Analysis
Global VCF Market Trends
- All regions are projected to experience market growth, though the rate of growth varies significantly:
- Middle East is expected to lead in growth rate.
- Followed by Africa and Asia-Pacific.
- North America has the lowest growth forecast, reflecting market maturity.
- Western Europe is similarly mature but ranks third globally due to its strong infrastructure.
- Market growth in less mature regions is driven by increased diagnosis, rising elderly populations, and better access to surgical solutions.
Global VCF Market Share Insights
- 1 Medtronic
- Global market leader in 2024, holding close to 50% of the total market value.
- Strong dominance in North America and Western Europe.
- Offers the KyphX(R) system and leads the PVA segment in multiple countries.
- 2 Stryker
- Ranked second globally in the VCF market.
- Products include:
- AutoPlex(TM) cement mixer and delivery system
- VertaPlex(TM), VertaPlex HV(TM), and SpinePlex(R) bone cements
- iVAS(TM) PVA system
- AVAflex Balloon System and AVAmax(R)
- Known for cost-effective alternatives and ease of use compared to competitors.
- 3 DePuy Synthes
- Third-largest competitor globally in 2024.
- Product portfolio includes:
- CONFIDENCE(TM) Spinal Cement System
- VERTECEM(TM) V+ bone cement
- Strong presence in North America and Western Europe.
- Focused on controlled delivery and stability in vertebral augmentation procedures.
Market Segmentation Summary
- Vertebroplasty
- Percutaneous Vertebral Augmentation (PVA)
Research Scope Summary
- Regions Covered
- North America: Canada, United States
- Latin America: Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela
- Western Europe: Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom
- Central & Eastern Europe: Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine
- Middle East: Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates
- Asia-Pacific: Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam
- Africa: Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda
- Base Year: 2024
- Forecast Period: 2025-2031
- Historical Data: 2021-2023
Quantitative Data
- Procedure Numbers
- Market Size
- Market Shares
- Market Forecasts
- Market Growth Rates
- Units Sold
- Average Selling Prices
Qualitative Data
- Market Growth Trends
- Market Limiters
- Competitive Analysis
- Mergers & Acquisitions
- Company Profiles
- Product Portfolios
- FDA Recalls
- Disruptive Technologies
Data Sources
- Primary Interviews with Industry Leaders
- Government Physician Data
- Regulatory Data
- Hospital Private Data
- Import & Export Data
- iData Research Internal Database